TEAM trial compares exemestane alone to sequential tamoxifen/exemestane therapy in breast cancer Feb. 8, 2011
SHELTER trial data reported on resminostat in sorafenib-resistant hepatocellular carcinoma Feb. 7, 2011
RSS